Of note, equivalent to the situation of inflammatory colitis, we have shown that DRD3-deficiency in CD4+ T-cells results in a complete attenuation of MPTP-induced neurodegeneration and the treatment of wild-type mice with a selective DRD3-antagonist significantly reduces the development of PD in two different animal models (46, 103). The gene discussed is CD4; the disease is Parkinson disease.